TNF Alpha Inhibitors Global Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease” report has been added to ResearchAndMarkets.com’s offering. The global TNF Alpha Inhibitors market is expected to grow from $38.56 billion in 2021 to $40.73 billion in 2022 at a compound annual growth rate (CAGR) of 5.6%. The market is expected … [Read more…]

CrestOptics’ DeepSIM Super Resolution Confocal Microscope Module Named by Microscopy Today as a Top 10 Best Microscopy Innovation Of 2022

Innovation awards announced at 2022 Microscopy & Microanalysis Meeting, Portland, Oregon, 31st July – 4th August, 2022 ROME–(BUSINESS WIRE)–CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has been recognised as developing one of the ten best microscopy innovations in the 2022 Microscopy Today Innovation Awards, DeepSIM. … [Read more…]

RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium

RWS’s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute’s Electronic Clinical Outcome Assessment (eCOA) Consortium to help … [Read more…]

Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that a planned futility interim analysis of the INTERLINK-1 Phase 3 study sponsored by AstraZeneca (LSE/STO/Nasdaq: AZN) did not meet a pre-defined threshold for efficacy. Based on this result and the recommendation of an Independent Data Monitoring … [Read more…]

Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic

Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation approach Ipsen to pay Marengo $45 million upfront with potential for additional milestone payments PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and Marengo Therapeutics, Inc. today announced a strategic partnership to … [Read more…]

SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)

Positive results show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19 LOS ANGELES & NEW TAIPEI CITY, Taiwan–(BUSINESS WIRE)–SyneuRx™ International (TPEX:6575), a global biotech company focused on the development of new classes of drugs for COVID-19 and multiple major central nervous system disorders, today announced results from its phase 2 clinical trial evaluating … [Read more…]

C2N’s New Blood Test Combining p-tau217 Ratio with Aβ42/40 Ratio Points to Accuracy Levels Comparable to Existing Standards of Care for Amyloid Diagnosis in the Evaluation of Patients with Cognitive Impairment

SAN DIEGO–(BUSINESS WIRE)–#AAIC2022–Data released from C2N Diagnostics, presented today at the Alzheimer’s Association International Conference, demonstrated that a blood test combining the Aβ42/40 ratio, a component of C2N’s commercially available PrecivityADTM blood test, with a unique p-tau217 ratio leads to testing performance that points to accuracy comparable to more complex amyloid PET imaging and invasive … [Read more…]

The MolinaCares Accord Supports Eastern Kentucky Flood Victims with $100,000 Donation

LOUISVILLE, Ky.–(BUSINESS WIRE)–The MolinaCares Accord (“MolinaCares”), in collaboration with Passport Health Plan by Molina Healthcare (“Passport by Molina”), has committed to donate $100,000 to the Governor’s Team Eastern Kentucky Flood Relief Fund and the Foundation for Appalachian Kentucky to support communities affected by the deadly flooding in eastern Kentucky. “Our hearts go out to all … [Read more…]

Performant Capital Creates Platform Delivering Managed Technology Services and Revenue Cycle Management to the Healthcare Industry

SAVANNAH, Ga.–(BUSINESS WIRE)–Performant Capital announced today that it has formed Provider Technology, LLC (“Provider Technology”) through the acquisitions of DavLong Business Solutions LLC and its affiliate Administrative Advantage LLC (collectively, “DBS”) and On Demand Solutions Inc. (“ODS”). Provider Technology is a leading technology provider of outsourced software and IT services, revenue cycle management (“RCM”) and … [Read more…]